Company Search:
Advanced Search
Sponsored Links
Bioton SA Company Snapshot
Bioton SA operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bioton SA with three other miscellaneous service companies in Europe: Molmed S.P.A. of ITALY (2019 sales of 34.34 million Euros [US$38.84 million] ), Genfit of FRANCE (40.96 million Euros [US$46.34 million] of which 100% was Therapeutic Drugs), and Brain Biotechnology Research and Information Network AG which is based in GERMANY (40.05 million Euros [US$45.30 million] of which 66% was BioIndustrial).

Sales Analysis. During the year ended December of 2019, sales at Bioton SA were 202.03 million Polish New Zlotys (US$51.17 million). This is a decrease of 16.2% versus 2018, when the company's sales were 241.17 million Polish New Zlotys.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Bioton SA
  Stock Performance Chart for Bioton SA
  Stock Data: Recent Stock Performance:
  Current Price (7/3/2020): 4.53
(Figures in Polish New Zlotys)
1 Week -2.6%   13 Weeks 6.8%  
4 Weeks 2.7%   52 Weeks 7.9%  
Bioton SA Key Data:
  Ticker: BIO Country: Poland
  Exchanges: WAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 202,032,000
(Year Ending Jan 2020).
Employees: 527
  Currency: Polish New Zlotys Market Cap: 388,964,826
  Fiscal Yr Ends: December Shares Outstanding: 85,864,200
  Share Type: Akcje Closely Held Shares: 51,501,625
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.